Business Description
![Verrica Pharmaceuticals Inc Verrica Pharmaceuticals Inc logo](https://static.gurufocus.com/logos/0C0000BGP8.png?14)
Verrica Pharmaceuticals Inc
NAICS : 325412
SIC : 2834
ISIN : US92511W1080
Description
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.
Financial Strength
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.05 | |||||
Equity-to-Asset | 0.02 | |||||
Debt-to-Equity | 30.8 | |||||
Debt-to-EBITDA | -0.63 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | -5.16 | |||||
Beneish M-Score | 110.12 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 4.5 | |||||
3-Year EPS without NRI Growth Rate | 5.9 | |||||
3-Year FCF Growth Rate | 12.2 | |||||
3-Year Book Growth Rate | -28.9 |
Momentum Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 49.03 | |||||
9-Day RSI | 45.55 | |||||
14-Day RSI | 45.72 | |||||
6-1 Month Momentum % | 26.36 | |||||
12-1 Month Momentum % | 43 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.17 | |||||
Quick Ratio | 3.04 | |||||
Cash Ratio | 2.53 | |||||
Days Inventory | 254.59 | |||||
Days Sales Outstanding | 207.43 | |||||
Days Payable | 383.81 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -18.6 | |||||
Shareholder Yield % | -6.96 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 79.63 | |||||
Operating Margin % | -838.45 | |||||
Net Margin % | -905.83 | |||||
FCF Margin % | -609.05 | |||||
ROE % | -219.61 | |||||
ROA % | -107.39 | |||||
ROIC % | -721.54 | |||||
ROC (Joel Greenblatt) % | -1557.66 | |||||
ROCE % | -116.43 |
GF Value Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 39.06 | |||||
PB Ratio | 208.33 | |||||
Price-to-Tangible-Book | 187.5 | |||||
EV-to-EBIT | -4.24 | |||||
EV-to-EBITDA | -4.3 | |||||
EV-to-Revenue | 35.42 | |||||
EV-to-Forward-Revenue | 11.22 | |||||
EV-to-FCF | -5.81 | |||||
Earnings Yield (Greenblatt) % | -23.58 | |||||
FCF Yield % | -17.06 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:VRCA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Verrica Pharmaceuticals Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 8.913 | ||
EPS (TTM) ($) | -1.76 | ||
Beta | 1.7 | ||
Volatility % | 113.81 | ||
14-Day RSI | 45.72 | ||
14-Day ATR ($) | 0.624402 | ||
20-Day SMA ($) | 7.9155 | ||
12-1 Month Momentum % | 43 | ||
52-Week Range ($) | 2.86 - 11.41 | ||
Shares Outstanding (Mil) | 42.42 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Verrica Pharmaceuticals Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Verrica Pharmaceuticals Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Verrica Pharmaceuticals Inc Frequently Asked Questions
What is Verrica Pharmaceuticals Inc(VRCA)'s stock price today?
The current price of VRCA is $7.50. The 52 week high of VRCA is $11.41 and 52 week low is $2.86.
When is next earnings date of Verrica Pharmaceuticals Inc(VRCA)?
The next earnings date of Verrica Pharmaceuticals Inc(VRCA) is 2024-08-08 Est..
Does Verrica Pharmaceuticals Inc(VRCA) pay dividends? If so, how much?
Verrica Pharmaceuticals Inc(VRCA) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |